Abstracts of the 29th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC)
- Poster presentation
- Open Access
Differential expression of PD-1 and Tim-3 marks activation versus exhaustion status of T cells in the tumor microenvironment
Journal for ImmunoTherapy of Cancer volume 2, Article number: P220 (2014)
Programmed Death 1 (PD-1) and T cell Ig and mucin domain-3 protein (Tim-3) are two immune checkpoint receptors (ICR) highly co-expressed on tumor infiltrating T lymphocytes (TIL). PD-1 has been shown to inhibit T cell activation and type 1 T cell responses, while Tim-3 has been proposed as a further marker of exhaustion on TIL [1, 2], leading us to investigate the phenotypic and functional characteristics of TIL with differential PD-1 and Tim-3 expression from head and neck cancer (HNC) patients. Our data showed that PD-1+Tim-3+ CD8+ and Foxp3- CD4+ TILs manifested high phosphorylated signal transducers and activators of transcription 1 (p-STAT1) and the associated Th1 transcription factor T-bet, which might correlate with T cell exhaustion, both at baseline and upon TCR stimulation. Moreover, the sorted PD-1+Tim-3+ CD8+ TILs expressed the lowest IFN-γ and TNF-α transcripts and the least amount of secreted IFN-γ upon TCR stimulation, indicating they are the most dysfunctional T cells in the tumor microenvironment (TME). Among CD4+CD25lo/- TIL subsets, PD-1hiTim-3- cells are more defective in terms of IFN-γ expression. Sorted PD-1intTim-3- CD8+ and CD4+CD25lo/- TILs showed higher TCR-stimulated expression of IFN-γ and TNF-α transcripts and secretion of IFN-γ, suggesting they are the most activated subsets. In addition, sorted PD-1+Tim-3+ and PD-1hiTim-3- TIL were less proliferative than other subsets, concomitant with lower expression of phosphorylated S6 (p-S6), while PD-1intTim-3-, PD-1-Tim-3+ and PD-1-Tim-3- TIL retained p-S6 activation or proliferation, suggesting that high expression of PD-1 on T cells interferes with TCR or Tim-3 signaling and associated cellular activation status. Taken together, PD-1+Tim-3+ and PD-1hiTim-3- TIL are most dysfunctional, while PD-1intTim-3- TIL are more activated in terms of both Th1 cytokine production and proliferation. These results provide a better understanding of the functional status of TIL subsets and roles of PD-1 and Tim-3 in regulating anti-tumor T cell response, as targets for cancer immunotherapy.
Jin HT, Anderson AC, Tan WG et al.: Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proceedings of the National Academy of Sciences of the United States of America. 2010, 107: 14733-8. 10.1073/pnas.1009731107.
Fourcade J, Sun Z, Benallaoua M et al.: Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. The Journal of experimental medicine. 2010, 207: 2175-86. 10.1084/jem.20100637.
Rights and permissions
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Li, J., Ferris, R.L. Differential expression of PD-1 and Tim-3 marks activation versus exhaustion status of T cells in the tumor microenvironment. j. immunotherapy cancer 2 (Suppl 3), P220 (2014). https://doi.org/10.1186/2051-1426-2-S3-P220
- Tumor Microenvironment
- Cancer Immunotherapy
- Cell Exhaustion
- Immune Checkpoint Receptor
- Cellular Activation Status